Jessenius Faculty of Medicine
in Martin
Comenius University Bratislava

Science and research

Research Focus

 

  • Diabetes mellitus as a cardiovascular risk factor

  • Molecular markers for the prediction of heart failure in obesity and diabetes mellitus

  • Resistance to antiplatelet therapy in patients with acute coronary syndrome and diabetes mellitus

  • Resistance to non-vitamin K oral anticoagulant therapy in patients with atrial fibrillation and diabetes mellitus

  • Risk factor stratification in patients with ischemic heart disease undergoing selective coronary angiography and interventional treatment

  • Adipokines as risk markers of cardiovascular diseases

  • Metabolic syndrome and the risk of type 2 diabetes mellitus and cardiovascular complications. The obesity paradox

  • Epidemiology of diabetes mellitus and metabolic syndrome

  • Obesity and molecular-genetic markers of cardiovascular and metabolic risk. Prediabetic states and subclinical inflammatory response

  • Metabolic syndrome and risk of venous thromboembolism

  • Metabolic syndrome, diabetes mellitus, and the risk of cancer

  • Diagnosis of early and late endothelial dysfunction, thrombocytopathy, coagulation and fibrinolysis disorders in diabetes mellitus, prediabetic states, and metabolic syndrome

  • Diagnosis of autoimmune type 1 diabetes mellitus using genetic and immunological markers

  • Hypoglycemia as a novel cardiovascular risk factor

  • Prevalence of hypoglycemia in hospitalized patients

  • Hypoglycemia as a limiting factor in the intensification of diabetes mellitus treatment

  • Hypoglycemia, CNS microvascular dysfunction, and cognitive impairment

  • Diagnosis of hypoglycemia unawareness

  • Post-transplant diabetes mellitus

  • Disorders of bone metabolism in patients with obesity, diabetes mellitus, and metabolic syndrome; interventional treatment with active vitamin D

  • Investigation of mineral-bone disease markers in diabetic nephropathy

  • Diagnosis of endothelial dysfunction, thrombocytopathy, and hemostatic and fibrinolytic abnormalities in diabetes mellitus and metabolic syndrome

  • Metabolic syndrome in patients with pulmonary embolism

  • Epidemiology of diabetes mellitus and metabolic syndrome

  • Diagnosis of autoimmune type 1 diabetes mellitus using genetic and immunological markers

  • Metabolic and immunological aspects of cardiac cachexia, nutritional support in patients with cardiac cachexia

 

 

Unique Methods

  • Assessment of counter-regulatory hormone response to hypoglycemia using clamp techniques

  • Investigation of insulin resistance using molecular markers and hyperinsulinemic euglycemic clamp diagnostics

  • Molecular characterization of metabolic syndrome

  • Analysis of adipose tissue hormones

  • Diagnosis of endothelial dysfunction, thrombocytopathy, hemostasis and fibrinolysis disorders in metabolic syndrome using molecular markers

  • Diagnosis of autoimmune diabetes mellitus using specialized immunological testing

  • Diagnosis of calcium metabolism disorders in diabetic nephropathy

  

 

Key Achievements 

  • Diagnosis of hypoglycemia unawareness using clamp methods

  • Diagnosis of insulin resistance via clamp techniques and molecular markers

  • Prevalence of diabetes mellitus and metabolic syndrome in the Slovak Republic

  • Diagnosis and prevalence of adult-onset autoimmune diabetes (LADA) in the Slovak Republic

  • Establishment of early insulin treatment indication criteria

  • Diagnosis of early and late endothelial dysfunction, thrombocytopathy, coagulation, and fibrinolysis disorders in diabetes mellitus and metabolic syndrome

  • Assessment of von Willebrand factor and soluble thrombomodulin to distinguish endothelial activation from damage

  • Diagnosis of local intestinal immunity using CD markers in biopsy samples assessed by flow cytometry in inflammatory bowel disease

  • Determination of the extent of intestinal inflammation using labeled leukocyte imaging (HMPAO-lymphocytes)